Sign in

Gabriele Corso

@gcorso.bsky.social
3.1K followers 101 following 119 posts

PhD student @MIT • Research on Generative Models for Biophysics and Drug Discovery

PostsRepliesMedia
Reposted by Gabriele Corso
Tom Westgarth @tomwestgarth.bsky.social · 09/01/2026
Extremely exciting day for open science. Another reason to be bullish on UK AI. Boltz, a startup that emerged out of MIT to be at the frontier of small molecule and protein design, has moved to London. I hear cases like this from a few founders, often a mix of fundamentals (talent)+personal.
091
Reposted by Gabriele Corso
Chaitanya K. Joshi @chaitjo.bsky.social · 08/01/2026
New blog 💙: I reflect on why I worked on what I worked on... I think a PhD is a very special time. You get to challenge yourself, push your boundaries, and grow. My thoughts go against the current AI/academia narrative online, so I hope you find it interesting. chaitjo.substack.com/p/phd-thesis...
chaitjo.substack.com
A Cambridge PhD thesis in three research questions
Geometric Deep Learning for Molecular Modelling and Design: A personal scientific journey
1112
Gabriele Corso @gcorso.bsky.social · 08/01/2026
Big news from Boltz today: we’re launching Boltz Lab, a new platform with new small-molecule + protein design agents, announcing Boltz PBC and a $28M seed round, and sharing a multi-year partnership with Pfizer. More below!
2243
Reposted by Gabriele Corso
Chaitanya K. Joshi @chaitjo.bsky.social · 03/12/2025
Introducing gRNAde: our own little "AlphaGo Moment" for RNA design! 🧬🚀 📝: tinyurl.com/gRNAde-paper Unlike proteins, RNA design has long relied on "wisdom of the crowd" (human experts) or the slow crawl of directed evolution — gRNAde changes that! 🧵👇
2296
Reposted by Gabriele Corso
MIT Jameel Clinic @mitjameelclinic.bsky.social · 30/10/2025
Join us today at MIT from 5pm-6pm for a seminar for BoltzGen, which is free and open to the public! Looking forward to seeing you all later today! 🤩 If you plan to attend, don't forget to RSVP so we can plan accordingly: luma.com/7474iho2 #AISky #AcademicSky
Blue and white graphic overlaid with text that reads "Introducing BoltzGen: Toward Universal Binder Design" followed by headshots and names of the speakers starting from the top "Hannes Stark, PhD student, MIT; Regina Barzilay, AI Faculty Lead, MIT Jameel Clinic; Tommi Jaakkola, Principal Investigator, MIT Jameel Clinic" Followed by event details: "When: Thursday, Oct. 30, 5pm-6pm; Where: 32-123, Stata Center; RSVP jclinic.mit.edu/events/boltzgen/"
051
Reposted by Gabriele Corso
Tim O'Donnell @timodonnell.bsky.social · 27/10/2025
One cool thing about BoltzGen is the flexibility of the conditioning information you can provide (e.g. "constrain the structure of these residues and also these but let their relative placement vary"). I'm really curious to see what the community does with it! github.com/HannesStark/...
github.com
GitHub - HannesStark/boltzgen
Contribute to HannesStark/boltzgen development by creating an account on GitHub.
151
Reposted by Gabriele Corso
Anton Bushuiev @anton-bushuiev.bsky.social · 27/10/2025
Very happy @roman-bushuiev.bsky.social and I joined the amazing team led by @hannes-stark.bsky.social to work on BoltzGen, a generative model for binder design based on Boltz-2. Excited what it will enable!
0134
Reposted by Gabriele Corso
Andrew Savinov @biosavinov.bsky.social · 27/10/2025
Thrilled to contribute to this exciting work on protein binder design together w/ @hannes-stark.bsky.social , Felix Faltings, Regina Barzilay, Tommi Jaakkola, and co. We applied BoltzGen to design novel antimicrobial peptides targeting DNA gyrase based on inhibitory protein fragments. (1/n)
153
Reposted by Gabriele Corso
Albert Vilella, PhD. @albertvilella.bsky.social · 27/10/2025
BoltzGen now published and available as MIT licensed software
0102
Reposted by Gabriele Corso
Brian Naughton @btnaughton.bsky.social · 27/10/2025
I’ve been testing BoltzGen a bit recently and while I haven’t done any experimental testing yet, the quality of the software is very clear. It installs, runs, logs everything, has tons of options. Very excited to test out the designs irl!
162
Reposted by Gabriele Corso
Hannes Stark @hannes-stark.bsky.social · 26/10/2025
Excited to release BoltzGen which brings SOTA folding performance to binder design! The best part of this project is collaborating with a broad network of leading wetlabs that test BoltzGen at an unprecedented scale, showing success on many novel targets and pushing the model to its limits!
310341
Gabriele Corso @gcorso.bsky.social · 17/09/2025
Pretty surreal when out of the blue you see your model up on an ad on highway billboards and airport screens 🤯 (pictures from San Diego Airport and a highway in SF)
1180
Gabriele Corso @gcorso.bsky.social · 09/09/2025
Boltz v2.2.1 out. A few improvements including support for .pdb templates, better treatment of stereochemistry in guidance potentials, and improved documentation. As always a great thank you to all those in the community who contributed via PR, raising issues or directly reporting issues to us.
1277
Gabriele Corso @gcorso.bsky.social · 09/09/2025
Sitting at the #AITHYRA symposium hearing about incredible new high-throughput datasets 🤯! If you have developed new data that you think could improve Boltz, e.g. protein small-molecule affinity, protein protein affinity, binding site (eg via proteomics), let's work together! 🤗
040
Reposted by Gabriele Corso
ChimeraX @chimerax.ucsf.edu · 20/08/2025
Here's how to predict binding of tens or hundreds of small molecules to protein assemblies using Boltz 2 in ChimeraX. Accuracy depends on how similar the ligands and binding pockets are to existing experimental structures. www.rbvi.ucsf.edu/chimerax/dat...
0279
Reposted by Gabriele Corso
Vojtech Spiwok @spiwokv.bsky.social · 21/08/2025
On #Boltz and #drugdesign by @gcorso.bsky.social #PragueBioML @elixircz.bsky.social
031
Reposted by Gabriele Corso
Martin Steinegger 🇺🇦 @martinsteinegger.bsky.social · 15/08/2025
If you use Boltz1/2, BioEmu, Chai1, or other MSA-dependent models, you’re likely using our ColabFold server. Please be considerate! Avoid large submissions across many IPs instead generate the MSA locally. Our server is an old-timer from 2014 and can’t handle that load.
36210
Reposted by Gabriele Corso
ChimeraX @chimerax.ucsf.edu · 24/07/2025
ChimeraX daily builds can predict binding affinity of small molecules using Boltz 2 on your Mac, Windows or Linux computer. www.rbvi.ucsf.edu/chimerax/dat...
18718
Reposted by Gabriele Corso
Alexander Ille @alexander-ille.bsky.social · 04/07/2025
Excited to share our work on modeling the human protein interactome in 3D. This currently includes 1,394 interaction structures predicted with Boltz-2. Grateful for the open-access resources making this possible! Preprint: doi.org/10.1101/2025...
0154
Reposted by Gabriele Corso
Alexis Verger 🧬🧫🧪 @alexis-verger.cpesr.fr · 19/06/2025
Boltz-2 : Towards accurate and efficient binding affinity prediction by @gcorso.bsky.social Saro Passaro and Jeremy Wohlwend youtu.be/iHDauMATkr0?...
youtu.be
Boltz-2: Towards Accurate and Efficient Binding Affinity Prediction
YouTube video by Valence Labs
062
Gabriele Corso @gcorso.bsky.social · 17/06/2025
Nice interview of Phil Sharp on the controversial birth of biotech and recombinant DNA with some great analogies to the current discourse on AI and gene editing! - YouTube www.youtube.com/watch?v=LLij... - Spotify spotifycreators-web.app.link/e/NNmzqnTjgUb - Apple podcasts.apple.com/us/podcast/h...
youtube.com
The Nobel that Sparked Biotech - Prof Phil Sharp
YouTube video by Health Horizons
060
Gabriele Corso @gcorso.bsky.social · 14/06/2025
Thank you everyone for attending the Boltz-2 Boston, San Francisco and Paris events this week! Given the success of the in-person seminars and the many requests, we are organizing a virtual seminar on Tuesday at 12pm ET / 6pm CET! Sign up here: lu.ma/4bpuwbsr
2161
Reposted by Gabriele Corso
Science X / Phys.org @sciencex.bsky.social · 10/06/2025
A new AI model jointly predicts protein structure and binding affinity, enabling rapid, accurate screening of small molecules and accelerating early-stage drug discovery. Boltz-2 is now open source.
phys.org
Protein-binding affinity model expands role of AI in drug discovery
Understanding how molecules interact is central to biology: from decoding how living organisms function to uncovering disease mechanisms and developing life-saving drugs.
022
Reposted by Gabriele Corso
Recursion @recursionpharma.bsky.social · 13/06/2025
Open science, activated. Since the release of Boltz-2 last Friday – the new open-source protein structure and protein binding affinity model from MIT & Recursion – we’ve been introducing the model to the broader community and the reception has been terrific. 🧵
132
Reposted by Gabriele Corso
Recursion @recursionpharma.bsky.social · 13/06/2025
On June 18 at the Molecular Machine Learning Conference (MoML) at MILA, Gabriele Corso, one of the lead researchers behind Boltz-2, will present more on this latest breakthrough in AI drug discovery alongside researchers from Valence. 👉 Learn more: portal.ml4dd.com #MOML2025
portal.ml4dd.com
Home | MoML 2025
021
Reposted by Gabriele Corso
Kyle Tretina @allthingsapx.bsky.social · 13/06/2025
Boltz-2 just dropped: open-source AI that predicts both protein complex folds ✚ binding affinities in one shot 🚀 This is a win for protein AI, but let's not forget MSAs, the bioinformatics backbone many structure models lean on.
172
Reposted by Gabriele Corso
Open Free Energy @openfree.energy · 13/06/2025
It's exciting to see our software used as a benchmark for cutting-edge AI methods!
061
Reposted by Gabriele Corso
C&EN (Chemical & Engineering News) @cenmag.bsky.social · 10/06/2025
A team led by Regina Barzilay, a computer science professor at MIT, has launched Boltz-2, an algorithm that unites protein folding and prediction of small-molecule binding affinity in one package. cen.acs.org/pharmaceutic... #chemsky 🧪
cen.acs.org
MIT and Recursion partner for AI drug discovery tool
Freely available Boltz-2 algorithm can predict small-molecule binding affinities
1155
Reposted by Gabriele Corso
MIT Jameel Clinic @mitjameelclinic.bsky.social · 10/06/2025
What a turnout! 🤯 Thank you to the 400+ attendees who came to listen to the first-ever Boltz-2 presentation in-person and for asking great questions! We look forward to seeing how Boltz-2 will empower future research in biomolecular structure prediction! 🧬🔥 #AIsky
142
Reposted by Gabriele Corso
The Mark Foundation for Cancer Research @themarkfdn.bsky.social · 09/06/2025
Boltz-2 is here—and it’s poised to transform preclinical drug development. We were lucky to get a preview from Regina Barzilay at our 2025 Scientific Symposium, and we’re proud to support her work on the @cancergrand.bsky.social Matchmakers team. www.cancergrandchallenges.org/news/boltz-2...
cancergrandchallenges.org
Boltz-2: democratising the future of drug design
Open source structure prediction with binding affinity
031
Reposted by Gabriele Corso
MIT Jameel Clinic @mitjameelclinic.bsky.social · 09/06/2025
'93 Nobel Prize laureate and Jameel Clinic Advisory Board Chair Phil Sharp breaks down why Boltz-2 is so groundbreaking. Join @gcorso.bsky.social + @jeremywohlwend.bsky.social today @ 4pm in Stata Center for their talk on Boltz-2! 🗓️RSVP: jclinic.mit.edu/events/unvei... 🎬: youtu.be/YDrFggLBEQw?...
youtu.be
'93 Nobel Laureate Phillip Sharp on significance of Boltz-2 and affinity binding
YouTube video by MIT Jameel Clinic - AI & Health
131
Reposted by Gabriele Corso
Jan Gebauer @gebauer.bsky.social · 09/06/2025
This sounds really interesting! Eager to test it with some structures we have lying around. 👍
021
Gabriele Corso @gcorso.bsky.social · 10/06/2025
Wow that was fast!! Looking forward to seeing this! @nboyd.bsky.social
061
Reposted by Gabriele Corso
Alexander Ille @alexander-ille.bsky.social · 08/06/2025
Truly remarkable work. Looking forward to using it!
031
Reposted by Gabriele Corso
Diego del Alamo @delalamo.xyz · 07/06/2025
Lots of work seems to have gone into the Boltz-2 data curation process to learn binding affinities
A very long description of how data was curated to learn affinity prediction
2262
Reposted by Gabriele Corso
Recursion @recursionpharma.bsky.social · 06/06/2025
More on Boltz-2, the new open source AI model from MIT & Recursion capable of predicting protein binding affinity w/ unprecedented speed, scale & accuracy -- the 1st model to combine structure & binding affinity prediction, approaching FEP accuracy w/ 1000X the speed. www.youtube.com/watch?v=gRtr...
youtube.com
New Open Source Model from MIT & Recursion Solves Major Hurdle in AI Drug Discovery
YouTube video by Recursion
0165
Reposted by Gabriele Corso
Roger Castells @rcastellsg.bsky.social · 06/06/2025
🤩🤩🤩 Boltz-2!!
051
Reposted by Gabriele Corso
Lee Zamparo @lzamparo.bsky.social · 06/06/2025
A Boltz-specifiic slack: boltz.bio/join-slack
boltz.bio
Join boltz-community on Slack
Slack is a new way to communicate with your team. It’s faster, better organized, and more secure than email.
011
Reposted by Gabriele Corso
Ben Fry @benf549.bsky.social · 07/06/2025
Trying out the Boltz-2 affinity prediction on the Exatecan binders we generated with LASErMPNN and NISE. Affinity prediction still clearly has room to improve, but the model seems to be able to identify the highest affinity mutant in this small dataset. Thanks to @gcorso.bsky.social and team! 1/2
171
Gabriele Corso @gcorso.bsky.social · 06/06/2025
Thank you everyone for the feedback on Boltz-2 and especially to those who have already helped us fix some elements of the repo! To keep the discussion going, please join our Slack community channel boltz-community.slack.com/join/shared_... and the events in Boston, SF, Paris and Montreal! 👇
170
Reposted by Gabriele Corso
MIT Jameel Clinic @mitjameelclinic.bsky.social · 06/06/2025
Delighted to announce the release of Boltz-2, which demonstrates unprecedented accuracy in predicting structure and binding affinity! Congrats to Sara Passaro, @gcorso.bsky.social + @jeremywohlwend.bsky.social on this stunning achievement! 📄Paper: bit.ly/boltz2-pdf 💻Code: github.com/jwohlwend/bo...
1146
Reposted by Gabriele Corso
MIT Jameel Clinic @mitjameelclinic.bsky.social · 06/06/2025
Join @gcorso.bsky.social and @jeremywohlwend.bsky.social on Monday, June 9 @ 4pm in the Stata Center for their presentation on the future of biomolecular modeling! 🗓️RSVP: jclinic.mit.edu/events/unvei...
jclinic.mit.edu
Unveiling Boltz-2 – MIT Jameel Clinic
021
Reposted by Gabriele Corso
Karel "CaCO3" Berka @krapnik.bsky.social · 06/06/2025
Binding affinities with #Alphafoldology using Boltz-2 ligands and ensembles included
071
Reposted by Gabriele Corso
Fay Lin @faylinphd.bsky.social · 06/06/2025
Boltz-2 now predicts molecular binding affinity at newfound speed and accuracy - and it's open source! The permissive MIT license allows commercial drug developers to apply proprietary data and offers an advance over the structure prediction capabilities of AlphaFold 3. tinyurl.com/37c96c6y
genengnews.com
Boltz-2 Released to Democratize AI Molecular Modeling for Drug Discovery
The MIT model predicts molecular binding affinity at newfound speed and accuracy, offering a powerful tool for commercial drug discovery.
1184
Reposted by Gabriele Corso
Fay Lin @faylinphd.bsky.social · 06/06/2025
In collaboration with @recursionpharma.bsky.social, the work was led by Gabriele Corso @gcorso.bsky.social, Saro Passaro, and Jeremy Wohlwend from the lab of Regina Barzilay at @mit.edu!
011
Reposted by Gabriele Corso
Rebecca Eccles @rebeccaeccles.bsky.social · 06/06/2025
Move over AlphaFold3. Boltz-2 has arrived, bringing affinity prediction for protein-small molecule interactions! Can’t wait to see what this group does next. Congrats to all @gcorso.bsky.social Was a pleasure writing this: www.cancergrandchallenges.org/news/boltz-2...
cancergrandchallenges.org
Boltz-2: democratising the future of drug design
Open source structure prediction with binding affinity
1378
Reposted by Gabriele Corso
da spreadsheet lover @chemotaxis.bsky.social · 06/06/2025
biologists are actually doing incredible things with AI
062